Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Efficacy of Bumetanide to Improve Cognitive Functions in Down Syndrome
- First Posted Date
- 2024-06-20
- Last Posted Date
- 2024-06-20
- Lead Sponsor
- Stefano Vicari
- Target Recruit Count
- 64
- Registration Number
- NCT06465823
- Locations
- 🇮🇹
Bambino Gesù Children's Hospital, Rome, Italy
News
No news found